Jacopo Secco

Prof. Dr. Jacopo Secco

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Journal of Wound Care
Verified
Journal Article
Closed access
GZGianluca Zoppo
Gianluca Zoppo
FMFrancesco Marrone
Francesco Marrone
MPMonica Pittarello
Monica Pittarello
MFMarco Farina
Marco Farina
AUAlberto Uberti
Alberto Uberti
ERElia Ricci
Elia Ricci
Objective: To report the clinical validation of an innovative, artificial intelligence (AI)-powered, portable and non-invasive medical device called Wound Viewer. The AI medical device uses dedicated sensors and AI algorithms to remotely collect objective and precise clinical data, including three-dimensional (3D) wound measurements, tissue composition and wound classification through the internationally recognised Wound Bed Preparation (WBP) protocol; this data can then be shared through a secure General Data Protection Regulation (GDPR)- and Health Insurance Portability and Accountability Act (HIPAA)-compliant data transfer system. This trial aims to test the reliability and precision of the AI medical device and its ability to aid health professionals in clinically evaluating wounds as efficiently remotely as at the bedside. Method: This non-randomised comparative clinical trial was conducted in the Clinica San Luca (Turin, Italy). Patients were divided into three groups: (i) patients with venous and arterial ulcers in the lower limbs; (ii) patients with diabetes and presenting with diabetic foot syndrome; and (iii) patients with pressure ulcers. Each wound was evaluated for area, depth, volume and WBP wound classification. Each patient was examined once and the results, analysed by the AI medical device, were compared against data obtained following visual evaluation by the physician and research team. The area and depth were compared with a Kruskal–Wallis one-way analysis of variations in the obtained distribution (expected p-value>0.1 for both tests). The WBP classification and tissue segmentation were analysed by directly comparing the classification obtained by the AI medical device against that of the testing physician. Results: A total of 150 patients took part in the trial. The results demonstrated that the AI medical device's AI algorithm could acquire objective clinical parameters in a completely automated manner. The AI medical device reached 97% accuracy against the WBP classification and tissue segmentation analysis compared with that performed in person by the physician. Moreover, data regarding the measurements of the wounds, as analysed through the Kruskal–Wallis technique, showed that the data distribution proved comparable with the other methods of measurement previously clinically validated in the literature (p=0.9). Conclusion: These findings indicate that remote wound assessment undertaken by physicians is as effective through the AI medical device as bedside examination, and that the device was able to assess wounds and provide a precise WBP wound classification. Furthermore, there was no need for manual data entry, thereby reducing the risk of human error while preserving high-quality clinical diagnostic data.

22 January 2018 in International Journal of Circuit Theory and Applications
Verified
Journal Article
Closed access
PDF file
Jacopo SeccoJacopo Secco
Jacopo Secco
MPMauro Poggio
Mauro Poggio
FCFernando Corinto
Fernando Corinto

4 May 2017 in IEEE Transactions on Circuits and Systems II: Express Briefs
Verified
Journal Article
Closed access
Jacopo SeccoJacopo Secco
Jacopo Secco
FCFernando Corinto
Fernando Corinto
ASAbu Sebastian
Abu Sebastian
Phase-Change Memory (PCM) is one of the most promising non-volatile memory technologies and is finding applications in areas such as storage-class memory and emerging non-von Neumann computing systems. Even though powerful physics-based models have been developed for these devices, there is a lack of simple and accurate circuit models to describe these elements. In this work, we exploit memristor theory to obtain a simple and reliable circuit model based on electrical variables such as charge and flux. This model is based on experimental measurements of PCM devices fabricated in the 90nm technology node.

11 August 2016
Verified
Conference Paper
Closed access
Jacopo SeccoJacopo Secco
Jacopo Secco
MFMarco Farina
Marco Farina
DDDanilo Demarchi
Danilo Demarchi
FCFernando Corinto
Fernando Corinto
MGMarco Gilli
Marco Gilli
The development of neuromorphic systems has increased in pace in the past years since the birth of industrial samples of memristors. In addition to developing the general technology, a strong interest in generating new applications for memristive systems is emerging. Cellular automata (CA) can be utilized for biomedical applications, primarily for image processing. Here, we have developed a CA that can be used to improve patient care, through the follow-up and monitoring of patients affected by topic wounds such as cutaneous ulcers.

20 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FMFrancesco Marrone
Francesco Marrone
Jacopo SeccoJacopo Secco
Jacopo Secco
BKBenedikt Kersting
Benedikt Kersting
MGManuel Le Gallo
Manuel Le Gallo
FCFernando Corinto
Fernando Corinto
LCLeon O. Chua
Leon O. Chua
Phase Change Memory (PCM) is an emerging technology exploiting the rapid and reversible phase transition of certain chalcogenides to realize nanoscale memory elements. PCM devices are being explored as non-volatile storage-class memory and as computing elements for in-memory and neuromorphic computing. It is well-known that PCM exhibits several characteristics of a memristive device. In this work, based on the essential physical attributes of PCM devices, we exploit the concept of Dynamic Route Map (DRM) to capture the complex physics underlying these devices to describe them as memristive devices defined by a state—dependent Ohm’s law. The efficacy of the DRM has been proven by comparing numerical results with experimental data obtained on PCM devices.

28 December 2024 in Scientific Reports
Verified
Journal Article
Open access
Jacopo SeccoJacopo Secco
Jacopo Secco
ESElisabetta Spinazzola
Elisabetta Spinazzola
MPMonica Pittarello
Monica Pittarello
ERElia Ricci
Elia Ricci
FPFabio Pareschi
Fabio Pareschi
Chronic wounds are a syndrome that affects around 4% of the world population due to several pathologies. The COV-19 pandemic has enforced the need of developing new techniques and technologies that can help clinicians to monitor the affected patients easily and reliably. In this prospective observational study a new device, the Wound Viewer, that works through a memristor-based Discrete-Time Cellular Neural Network (DT-CNN) has been developed and tested through a clinical trial of 150 patients. The WV has been developed to serve as the state-of-art tool, capable to return the actual clinical information that is most needed by the caregivers: through the WBP scale, it classifies four classes of wounds by the type of tissue: A-only granular tissue; B-50% slough; D-necrosis. This work aims to describe in depth the technology and the computational techniques that have been implemented, and to demonstrate reliability in automatically identifying, classifying through internationally accepted clinical scales and measuring such wounds, that peaked to over a 90% of accuracy.